Video Experimental Relacionado
Updated: Sep 9, 2025
02:14
Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
461
Un bebé con enfermedad de Kawasaki que tiene sangrado gastrointestinal debido a múltiples úlceras gástricas
Takeru Kanazawa1, Tomokazu Nakagami1, Jyoji Yoshizawa1
1Children's Medical Center, Showa Medical University Koto Toyosu Hospital Tokyo Japan.
Journal of general and family medicine
|September 4, 2025
Resumen
El sangrado gastrointestinal severo, una complicación rara de la enfermedad de Kawasaki (KD), se produjo en un bebé a pesar del tratamiento preventivo. Este caso destaca la necesidad de un monitoreo cuidadoso de los pacientes con KD, especialmente los que toman esteroides y AINE, para prevenir el sangrado.
Área de la Ciencia:
- Reumatología pediátrica
- Gastroenterología
- Vasculitis sistémica
Sus antecedentes:
- La enfermedad de Kawasaki (KD) es una de las principales causas de enfermedad cardíaca adquirida en niños.
- Los síntomas gastrointestinales (GI) son comunes en KD, pero el sangrado gastrointestinal severo es una complicación rara.
- El tratamiento estándar de KD incluye inmunoglobulina intravenosa (IVIG), aspirina y corticosteroides.
Objetivo del estudio:
- Para informar de un caso raro de sangrado gastrointestinal grave en un paciente con enfermedad de Kawasaki incompleta.
- Investigar las posibles causas de sangrado gastrointestinal en pacientes con KD, incluidos los efectos secundarios de los medicamentos.
- Hacer hincapié en la importancia de la vigilancia de la IG en la gestión de la KD.
Principales métodos:
- Informe de caso de una hembra de 11 meses diagnosticada con enfermedad incompleta de Kawasaki.
- Revisión de la presentación clínica, análisis de diagnóstico y tratamiento.
- Análisis de los factores que contribuyen al sangrado gastrointestinal grave, incluidos los medicamentos.
Principales resultados:
- El paciente desarrolló múltiples úlceras gástricas y sangrado gastrointestinal grave que requirió una transfusión de sangre.
- La hemorragia se produjo a pesar de la terapia profiláctica con antagonistas de los receptores H2.
- Entre los posibles factores contribuyentes identificados se encuentran la enfermedad coronaria en sí misma y los efectos combinados de los corticosteroides y los AINE.
Conclusiones:
- El sangrado gastrointestinal puede ser una complicación directa y grave de la enfermedad de Kawasaki.
- Los corticosteroides y los AINE pueden aumentar el riesgo de hemorragia gastrointestinal en pacientes con enfermedad coronaria.
- El monitoreo vigilante de las complicaciones gastrointestinales y la investigación adicional de estrategias preventivas son cruciales para el manejo de KD.
Videos de Conceptos Relacionados
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
308
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
308
01:28Esophageal Varices-II: Clinical Features and Management
133
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
133
01:17Gastritis-II: Pathophysiology
537
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
537
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
01:24Esophageal Varices-I: Introduction
324
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
324
01:30Peptic Ulcer Disease I: Introduction
282
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
282